Stockholm, Sweden – November 4-6, 2024 – Metanotitia (脉图) stood out as one of the key highlights at Bio Europe 2024, with its advanced digital healthcare products and precision health management solutions. The event attracted thousands of industry leaders, scientists, investors, and policymakers from over 50 countries and regions worldwide, aiming to promote international cooperation and innovation in the biotechnology sector.
Throughout the three-day conference, the Metanotitia team actively showcased its innovations in AI-assisted diagnostics, multidimensional health monitoring, and personalized health management. The company engaged in deep discussions with internationally renowned pharmaceutical giant Johnson & Johnson, Germany's leading research institution Fraunhofer Health, as well as numerous cutting-edge biotech companies and clinical research organizations (CROs). Through a series of strategic dialogues, Metanotitia successfully expanded its international collaboration projects. These partnerships span a wide range of areas, from drug development support to health data management, with plans to introduce Metanotitia's technologies and products to more countries and regions, contributing to the global healthcare industry's advancement.
Additionally, Metanotitia held in-depth talks with local investment promotion agencies, exploring the potential for establishing research and development centers and technology transfer hubs in the region.
Bio Europe’s mission is to foster global collaboration and development within the biotechnology industry, particularly in biopharmaceuticals, innovative drug development, precision medicine, and diagnostic technologies. Metanotitia exemplifies this vision as a leader in the digital health space. Through its participation in this prestigious event, Metanotitia not only demonstrated its technological strength and innovation in the digital healthcare field but also highlighted the competitive potential of Chinese tech companies in the international market. Looking ahead, Metanotitia will continue to partner with global collaborators to drive groundbreaking advancements in the health sector and make significant contributions to human health and well-being.
About Metanotitia:
Metanotitia is a pioneering data-driven biotech company that specializes in digital health solutions, leveraging cutting-edge technologies in AI, health monitoring, and precision health management to improve healthcare outcomes globally.
